- Report
- March 2024
- 191 Pages
Global
From €3241EUR$3,374USD£2,766GBP
€3601EUR$3,749USD£3,074GBP
- Report
- March 2024
- 184 Pages
Global
From €3241EUR$3,374USD£2,766GBP
€3601EUR$3,749USD£3,074GBP
- Report
- April 2023
- 353 Pages
Global
From €4789EUR$5,161USD£3,950GBP
- Report
- February 2024
- 408 Pages
Global
From €4754EUR$4,950USD£4,059GBP
- Report
- February 2024
- 250 Pages
Global
From €4802EUR$5,000USD£4,100GBP
- Report
- January 2024
- 200 Pages
Global
From €4802EUR$5,000USD£4,100GBP
- Report
- March 2024
- 181 Pages
Global
From €4754EUR$4,950USD£4,059GBP
- Report
- October 2023
- 148 Pages
Global
From €2400EUR$2,499USD£2,049GBP
- Report
- November 2023
- 175 Pages
Global
From €4706EUR$4,900USD£4,018GBP
- Report
- October 2023
- 190 Pages
Global
From €4706EUR$4,900USD£4,018GBP
- Report
- April 2023
- 167 Pages
Global
From €2401EUR$2,500USD£2,050GBP
- Report
- March 2023
- 180 Pages
Global
From €2401EUR$2,500USD£2,050GBP
- Report
- April 2023
- 150 Pages
Global
From €4658EUR$4,850USD£3,977GBP
- Report
- February 2024
- 120 Pages
Global
From €4106EUR$4,275USD£3,505GBP
€4562EUR$4,750USD£3,895GBP
- Report
- December 2023
- 799 Pages
Global
From €4609EUR$4,799USD£3,935GBP
- Report
- July 2023
- 356 Pages
Global
From €4609EUR$4,799USD£3,935GBP
- Report
- April 2023
- 520 Pages
Global
From €3165EUR$3,295USD£2,702GBP
- Report
- June 2023
- 56 Pages
Global
€2353EUR$2,450USD£2,009GBP
- Report
- July 2023
- 80 Pages
Global
From €4562EUR$4,750USD£3,895GBP
- Report
- February 2024
- 169 Pages
Global
From €4754EUR$4,950USD£4,059GBP
The Protein Drugs market is a subset of the larger Drug Discovery industry. It focuses on the development of drugs that are based on proteins, such as monoclonal antibodies, cytokines, and growth factors. These drugs are used to treat a variety of diseases, including cancer, autoimmune disorders, and infectious diseases. Protein drugs are typically developed through recombinant DNA technology, which involves the manipulation of genetic material to create a desired protein.
The Protein Drugs market is highly competitive, with many companies vying for a share of the market. Companies in the market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are engaged in research and development of new protein drugs, as well as the marketing and distribution of existing drugs. Show Less Read more